2nd Quarter - Report

TIBER CREEK GROUP for MERCK & CO., INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Issues related to vaccines.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
ANDREW MCKECHNIE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to vaccines, S. 469 Affordable and Safe Prescription Drug Importation Act, H.R. 1245 Affordable and Safe Prescription Drug Importation Act, issues related to pharmaceutical pricing and transparency. S. 934 - FDARA, HR 1409 - FDARA. S. 1348 - SPIKE Act of 2017.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
ANDREW MCKECHNIE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1348 (115th), S. 934 (115th), H.R. 1245 (115th), H.R. 1409 (115th), S. 469 (115th)

Medicare/Medicaid MMM

Issues related to pharmaceutical pricing and transparency.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
ANDREW MCKECHNIE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.